Hib-MenC-TT

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Meningococcal

Phase 2

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

CompletedNCT00135486

GlaxoSmithKlineInfections, Meningococcal

Start: 2002-03-31End: 2003-01-31Updated: 2016-09-16

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

CompletedNCT00135564

GlaxoSmithKlineInfections, Meningococcal

Start: 2003-01-31End: 2003-07-31Updated: 2016-09-16

Related Papers

Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.

2007-02-0729 citations